page contents

World-first ketamine trial shows promise for geriatric depression

Australian researchers have completed the world’s first randomised control trial (RCT) assessing the efficacy and safety of ketamine as a treatment for depression in elderly patients.

The results, published in the latest American Journal of Geriatric Psychiatry, provide preliminary evidence suggesting ketamine’s effectiveness as an antidepressant when delivered in repeated intravenous doses.

Led by a team of researchers from UNSW Sydney and Black Dog Institute, the trial tested different doses of ketamine among 16 older age participants (aged over 60 years) who had treatment-resistant depre…
Geriatrics and Aging – Healthcanal.com

Leave a Reply

Your email address will not be published. Required fields are marked *

*